Mirna Therapeutics, Inc. (NASDAQ:MIRN) will be releasing its earnings data on Monday, August 14th. Analysts expect Mirna Therapeutics to post earnings of ($0.11) per share for the quarter.
Mirna Therapeutics, Inc. (MIRN) opened at 1.66 on Friday. The company has a 50 day moving average price of $1.68 and a 200-day moving average price of $1.90. The company’s market capitalization is $34.63 million. Mirna Therapeutics, Inc. has a 12-month low of $1.12 and a 12-month high of $4.19.
WARNING: “Mirna Therapeutics, Inc. (MIRN) to Release Earnings on Monday” was first reported by Community Financial News and is owned by of Community Financial News. If you are accessing this report on another site, it was illegally stolen and reposted in violation of United States and international copyright and trademark legislation. The legal version of this report can be viewed at https://www.com-unik.info/2017/08/12/mirna-therapeutics-inc-mirn-to-release-earnings-on-monday.html.
Mirna Therapeutics Company Profile
Mirna Therapeutics, Inc is a clinical-stage biopharmaceutical company developing a pipeline of micro ribonucleic acid (RNA)-based oncology therapeutics. The Company is developing mimics of naturally occurring microRNAs that are designed to restore the tumor suppressor activity and aid appropriate anti-tumor immune response.
What are top analysts saying about Mirna Therapeutics Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Mirna Therapeutics Inc. and related companies.